Document is current

Article History

Received: 18 June 2024

Accepted: 4 March 2025

First Online: 2 April 2025

Change Date: 28 April 2025

Change Type: Update

Change Details: The section ‘Supplementary Information: Below is the link to the electronic supplementary material’ was included erroneously in the original article and has been removed.

Declarations

:

: The authors declare that this study received funding from Pfizer Inc. Dharanija Rao is an employee of Pfizer and has stock in Pfizer. The funder had the following involvement with the study: Pfizer-affiliated authors were involved in the review and feedback for current manuscript and budget from Pfizer Publication Team. Nancy Moldawer served on speaker’s bureaus for Exelixis; has received reimbursement for travel to International Kidney Cancer Symposium. Edwin Posadas received consulting fees from Bayer and Janssen, served on speaker’s bureaus for Bayer, received support for travel from Bayer, and is vice-president of the Catholic Medical Association-LA Guild. Greg Biddulph is a patient author and has no conflicts of interest to declare.

: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.